Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) announced that it has passed Food and Drug Administration (FDA) tests for UV Ink used on the company’s AccurioJet KM-1 digital press in the printing of packaging for food & beverage, health & beauty aids and pharmaceutical & nutraceutical products that come under the guidance and oversight of the Administration.
Toxicology risk assessment tests, conducted in accordance with FDA regulations at certified laboratories, and validated by the Underwriters Laboratories, concluded that the UV ink used by the AccurioJet KM-1 on consumer product packaging materials was considered safe for indirect food contact.
As part of the certification process, the UV ink was tested under a range of environmental conditions that mimicked potential consumer applications and storage. This included labels and packaging materials subjected to room temperature, refrigeration, freezing temperatures, and microwave or oven heat – passing all FDA requirements for ink used on packaged goods.
“This certification provides an extra level of assurance to our industrial print customers, as well as to consumers, that the ink used in our AccurioJet KM-1 press is safe when used on a variety packaging materials and under a full range of storage conditions,” said Bill Troxil, senior vice president, strategic business development at Konica Minolta.